Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07762885
What this trial is testing

Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery

Who this might be right for
Ductal Carcinoma In Situ, DCIS
Fudan University 636
Early research (Phase 1)Active Not RecruitingNCT04704661
What this trial is testing

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Who this might be right for
Advanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more
National Cancer Institute (NCI) 51
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Not applicableStudy completedNCT00880503
What this trial is testing

Collection of Tissue Samples for Study of Multidrug Resistance

Who this might be right for
Breast CarcinomaBreast CancerMedullary Thyroid Carcinoma
National Cancer Institute (NCI) 325
Very early researchActive Not RecruitingNCT02872025
What this trial is testing

Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)

Who this might be right for
Carcinoma, Intraductal, Noninfiltrating
Laura Esserman 42
Early research (Phase 1)Looking for participantsNCT07630961
What this trial is testing

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)HR+/HER2- Ductal Breast Cancer (BC)+4 more
Novartis Pharmaceuticals 66
Early research (Phase 1)Looking for participantsNCT04150042
What this trial is testing

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Who this might be right for
Pancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more
General Oncology, Inc. 24
Not applicableUnknownNCT04177056
What this trial is testing

Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief

Who this might be right for
Bone MetastasesProstate CancerBreast Cancer+2 more
Hamilton Health Sciences Corporation 40
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Not applicableWithdrawnNCT00083044
What this trial is testing

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Who this might be right for
Breast Cancer
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT02874430
What this trial is testing

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Who this might be right for
Breast CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Not applicableEnded earlyNCT01409811
What this trial is testing

Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid

Who this might be right for
Estrogen Receptor-positive Breast CancerInvasive Ductal Breast CarcinomaProgesterone Receptor-positive Breast Cancer+4 more
City of Hope Medical Center 9
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Not applicableStudy completedNCT05086705
What this trial is testing

EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In Situ+1 more
Ohio State University Comprehensive Cancer Center 50
Not applicableWithdrawnNCT00041353
What this trial is testing

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Who this might be right for
Breast Cancer
Fox Chase Cancer Center
Early research (Phase 1)Study completedNCT00003761
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Testing effectiveness (Phase 2)Study completedNCT01593020
What this trial is testing

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 54
Early research (Phase 1)Ended earlyNCT03343613
What this trial is testing

LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerRenal Cell Carcinoma+1 more
Eli Lilly and Company 60
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Next Page